NovaBridge Biosciences (NBP) Long-Term Debt Repayments (2019 - 2020)

NovaBridge Biosciences (NBP) reported Long-Term Debt Repayments of $15.1 million for Q4 2020, down 33.53% year-over-year from $22.7 million in Q1 2020, and down 33.53% quarter-over-quarter from $22.7 million in Q4 2019.

NovaBridge Biosciences (NBP) Long-Term Debt Repayments (2019 - 2020) Analysis & Trends

NovaBridge Biosciences (NBP) has 2 years of Long-Term Debt Repayments data on file, last reported at $15.1 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
2 Belite Bio 55,234.00 Bn 55,234.00 Bn - -
3 Quantum Biopharma 17,823.14 Bn 17,823.14 Bn - -21,671.00
4 Legend Biotech 3,624.50 Bn 3,624.21 Bn 242.10 Mn -
5 Akari Therapeutics 1,745.73 Bn 1,745.73 Bn - -
6 Evaxion A 1,540.85 Bn 1,540.84 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 112.57 Bn 105.33 Bn 2.59 Bn -
9 Abivax 93.46 Bn 93.46 Bn - -
10 NovaBridge Biosciences 331.49 Mn 120.65 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 15.09 Mn
Dec 31, 2020 15.09 Mn
Dec 31, 2019 22.70 Mn
Dec 31, 2019 22.70 Mn